The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
The footage, taken from a dead Islamic State militant, shows the fighters in a chaotic and panicked battle with Peshmerga forces.
Solicitors acting for 20 of the families said they were "appalled to see the shambles in South Yorkshire Police" following the inquest.
The two men are accused of meeting with Mohamed Abrini and giving him money.